A randomised clinical trial of docetaxel and estrogen in patients with castration resistant prostate cancer
Not Applicable
Recruiting
- Conditions
- Castration-resistant prostate cancer
- Registration Number
- JPRN-UMIN000006120
- Lead Sponsor
- Department of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who received cytotxic-chemotherapy prior to this trial. 2)Patients who received estrogen therapy prior to this trial. 3)Patients who received radiation therapy to primary cancer site within 3 monthsprior to this trial. 4)Patients who diagnosed pulmonary fibrosis or interstitial pneumonitis. 5)Patients who have a history of acute myocardial infarction within 6 months. 6)Severe cormobidity (DM, heart disease, liver dysfunction etc.)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to treatment failure
- Secondary Outcome Measures
Name Time Method